CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase II, Pilot Study, Open Label, Multicenter, Evaluating Dual Antiretroviral Therapy With Long-acting Cabotegravir/Lenacapavir
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06657885
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:38.411734+00:00
- Published At
- 2026-01-14T00:00:00+00:00
- Record Updated At
- 2026-01-14
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["HIV1 Infection", "Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment", "CABOTEGRAVIR", "LENACAPAVIR", "Stable Oral Antiretroviral Treatment for at Least 6 Months"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-14"- protocolSection.identificationModule.nctId
"NCT06657885"- protocolSection.identificationModule.officialTitle
"Phase II, Pilot Study, Open Label, Multicenter, Evaluating Dual Antiretroviral Therapy With Long-acting Cabotegravir/Lenacapavir"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.